Literature DB >> 21267545

Skeletal mineralization defects in adult hypophosphatasia--a clinical and histological analysis.

F Barvencik1, F Timo Beil, M Gebauer, B Busse, T Koehne, S Seitz, J Zustin, P Pogoda, T Schinke, M Amling.   

Abstract

UNLABELLED: Histomorphometry and quantitative backscattered electron microscopy of iliac crest biopsies from patients with adult hypophosphatasia not only confirmed the expected enrichment of non-mineralized osteoid, but also demonstrated an altered trabecular microarchitecture, an increased number of osteoblasts, and an impaired calcium distribution within the mineralized bone matrix.
INTRODUCTION: Adult hypophosphatasia is an inherited disorder of bone metabolism caused by inactivating mutations of the ALPL gene, encoding tissue non-specific alkaline phosphatase. While it is commonly accepted that the increased fracture risk of the patients is the consequence of osteomalacia, there are only few studies describing a complete histomorphometric analysis of bone biopsies from affected individuals. Therefore, we analyzed iliac crest biopsies from eight patients and set them in direct comparison to biopsies from healthy donors or from individuals with other types of osteomalacia.
METHODS: Histomorphometric analysis was performed on non-decalcified sections stained either after von Kossa/van Gieson or with toluidine blue. Bone mineral density distribution was quantified by backscattered electron microscopy.
RESULTS: Besides the well-documented enrichment of non-mineralized bone matrix in individuals suffering from adult hypophosphatasia, our histomorphometric analysis revealed alterations of the trabecular microarchitecture and an increased number of osteoblasts compared to healthy controls or to individuals with other types of osteomalacia. Moreover, the analysis of the mineralized bone matrix revealed significantly decreased calcium content in patients with adult hypophosphatasia.
CONCLUSIONS: Taken together, our data show that adult hypophosphatasia does not solely result in an enrichment of osteoid, but also in a considerable degradation of bone quality, which might contribute to the increased fracture risk of the affected individuals.

Entities:  

Mesh:

Year:  2011        PMID: 21267545     DOI: 10.1007/s00198-011-1528-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  41 in total

1.  The mineralization density of iliac crest bone from children with osteogenesis imperfecta.

Authors:  A Boyde; R Travers; F H Glorieux; S J Jones
Journal:  Calcif Tissue Int       Date:  1999-03       Impact factor: 4.333

2.  Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia.

Authors:  Michael P Whyte; Deborah Wenkert; William H McAlister; M Zulf Mughal; Anthony J Freemont; Richard Whitehouse; Eileen M Baildam; Stephen P Coburn; Lawrence M Ryan; Steven Mumm
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

3.  Neonatal hypophosphatasia and seizures. A case report.

Authors:  P Smilari; D M M Romeo; P Palazzo; C Meli; G Sorge
Journal:  Minerva Pediatr       Date:  2005-10       Impact factor: 1.312

Review 4.  Heritable metabolic and dysplastic bone diseases.

Authors:  M P Whyte
Journal:  Endocrinol Metab Clin North Am       Date:  1990-03       Impact factor: 4.741

5.  Scanning electron microscopy in bone pathology: review of methods, potential and applications.

Authors:  A Boyde; E Maconnachie; S A Reid; G Delling; G R Mundy
Journal:  Scan Electron Microsc       Date:  1986

6.  A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensities.

Authors:  P Roschger; H Plenk; K Klaushofer; J Eschberger
Journal:  Scanning Microsc       Date:  1995-03

7.  Novel missense and frameshift mutations in the tissue-nonspecific alkaline phosphatase gene in a Japanese patient with hypophosphatasia.

Authors:  H Orimo; Z Hayashi; A Watanabe; T Hirayama; T Hirayama; T Shimada
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

8.  Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients.

Authors:  Matthias Priemel; Christoph von Domarus; Till Orla Klatte; Steffen Kessler; Julia Schlie; Simon Meier; Nils Proksch; Frederic Pastor; Clemens Netter; Thomas Streichert; Klaus Püschel; Michael Amling
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

9.  Infantile hypophosphatasia: autosomal recessive transmission to two related sibships.

Authors:  C A Moore; J C Ward; M L Rivas; H L Magill; M P Whyte
Journal:  Am J Med Genet       Date:  1990-05

Review 10.  Bone mineralization density distribution in health and disease.

Authors:  P Roschger; E P Paschalis; P Fratzl; K Klaushofer
Journal:  Bone       Date:  2007-11-12       Impact factor: 4.398

View more
  25 in total

Review 1.  Role of Phosphate in Biomineralization.

Authors:  Sanjay Kumar Bhadada; Sudhaker D Rao
Journal:  Calcif Tissue Int       Date:  2020-07-25       Impact factor: 4.333

2.  Low-energy trauma-induced intercondylar femoral fracture.

Authors:  Mathias Aeby; Tobias Wyss; Birgit Mentrup; Erdmute Kunstmann; Franz Jakob; Daniel Aeberli
Journal:  Clin Cases Miner Bone Metab       Date:  2016-10-05

Review 3.  [Pathological and metabolic bone diseases: Clinical importance for fracture treatment].

Authors:  R Oheim
Journal:  Unfallchirurg       Date:  2015-12       Impact factor: 1.000

4.  Abnormal bone turnover in individuals with low serum alkaline phosphatase.

Authors:  L López-Delgado; L Riancho-Zarrabeitia; M T García-Unzueta; J A Tenorio; M García-Hoyos; P Lapunzina; C Valero; J A Riancho
Journal:  Osteoporos Int       Date:  2018-06-12       Impact factor: 4.507

Review 5.  Bone quality changes associated with aging and disease: a review.

Authors:  Adele L Boskey; Laurianne Imbert
Journal:  Ann N Y Acad Sci       Date:  2017-12       Impact factor: 5.691

6.  Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia.

Authors:  Lothar Seefried; Jasmin Baumann; Sarah Hemsley; Christine Hofmann; Erdmute Kunstmann; Beate Kiese; Yue Huang; Simon Chivers; Marie-Anne Valentin; Babul Borah; Ronenn Roubenoff; Uwe Junker; Franz Jakob
Journal:  J Clin Invest       Date:  2017-04-24       Impact factor: 14.808

Review 7.  Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.

Authors:  Allison L Brichacek; Candice M Brown
Journal:  Metab Brain Dis       Date:  2018-10-04       Impact factor: 3.584

Review 8.  Hypophosphatasia: Biological and Clinical Aspects, Avenues for Therapy.

Authors:  Jean Pierre Salles
Journal:  Clin Biochem Rev       Date:  2020-02

9.  Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all.

Authors:  F Genest; L Seefried
Journal:  Osteoporos Int       Date:  2018-05-17       Impact factor: 4.507

Review 10.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.